Light Horse Therapeutics
Drug Discovery
Light Horse Therapeutics valuation and funding history | Last updated: January 9, 2025 | 1 funding rounds
Current Valuation
N/A
As of January 9, 2025
Total Funding Raised
N/A
Across 1 round
Last Round
Early Stage VC (Series A)
$62.0M
Last Funding
Jan 2025
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| January 9, 2025 | Early Stage VC (Series A) | $62.0M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Light Horse Therapeutics is currently valued at N/A as of January 9, 2025.
Explore More Data
Detailed analysis for Light Horse Therapeutics
What is Light Horse Therapeutics Worth in 2026?
Light Horse Therapeutics is a leading private company in the Drug Discovery sector. Track Light Horse Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Light Horse Therapeutics Valuation is Determined
Private company valuations like Light Horse Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.